Adenosine A2A receptor antagonists as a novel non-dopaminergic therapy for Parkinson's disease: A potential mechanism of the antiparkinsonian action

被引：0

作者：

Mori, A. ^{[1
]}

机构：

[1] Kyowa Hakko Kogyo Co Ltd, Tokyo, Japan

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2006年 / 248卷 / 1-2期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

186

引用

页码：319 / 319

页数：1

共 50 条

[21] Adenosine A2A receptor antagonists in Parkinson's disease: still in the running
Antonini, Angelo
Poewe, Werner
[J]. LANCET NEUROLOGY, 2014, 13 (08): : 748 - 749
[22] Adenosine A2A receptor antagonists for Parkinson's disease -: Rationale, therapeutic potential and clinical experience
Hauser, RA
Schwarzschild, MA
[J]. DRUGS & AGING, 2005, 22 (06) : 471 - 482
[23] Novel neuroprotection by caffeine and adenosine A2A receptor antagonists in animal models of Parkinson's disease
Kalda, Anti
Yu, Liqun
Oztas, Emin
Chen, Jiang-Fan
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 9 - 15
[24] New therapies for the treatment of Parkinson's disease:: Adenosine A2A receptor antagonists
Pinna, A
Wardas, J
Simola, N
Morelli, M
[J]. LIFE SCIENCES, 2005, 77 (26) : 3259 - 3267
[25] New adenosine A2A receptor antagonists:: Actions on Parkinson's disease models
Pinna, A
Volpini, R
Cristalli, G
Morelli, M
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 512 (2-3) : 157 - 164
[26] Caffeine, Chocolate and Adenosine A2A Receptor Antagonists in the Treatment of Parkinson's Disease
Reichmann, Heinz
[J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2023, 91 (06) : 256 - 261
[27] Adenosine A2A antagonists:: potential preventive and palliative treatment for Parkinson's disease
Morelli, M
[J]. EXPERIMENTAL NEUROLOGY, 2003, 184 (01) : 20 - 23
[28] Non-dopaminergic imaging in Parkinson's disease
Marek, K.
Jennings, D.
Russell, D.
Tamagnan, G.
Zubal, G.
Seibyl, J.
[J]. MOVEMENT DISORDERS, 2008, 23 (01) : S64 - S64
[29] Non-dopaminergic treatments for Parkinson's disease
Derkinderen, P.
[J]. REVUE NEUROLOGIQUE, 2010, 166 (10) : 811 - 815
[30] A2A receptor antagonists:: Potential therapeutic effects in Parkinson's disease
Morelli, M
Carta, AR
Pinna, A
Pala, P
[J]. BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S2 - S2

← 1 2 3 4 5 →